From: Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation
Characteristics | Overall patients (n = 503) | P value | ||
---|---|---|---|---|
No NeOAF (n = 263) | NeOAF to SR (n = 165) | NeOAF to AF (n = 75) | ||
Age, years | 69.5 ± 15.6 | 77.8 ± 10.3†| 76.2 ± 11.0a | <0.01 |
Male, n (%) | 174 (66.2) | 90 (54.5)†| 46 (61.3) | 0.06 |
Comorbidities, n (%) | ||||
Hypertension | 145 (55.1) | 111 (67.3)†| 44 (58.7) | 0.04 |
Heart failure | 25 (9.5) | 35 (21.2)†| 15 (20.0)a | <0.01 |
Coronary artery disease | 90 (34.2) | 70 (42.4) | 37 (49.3)a | 0.04 |
Cerebrovascular disease | 56 (21.3) | 53 (32.1)†| 23 (30.7) | 0.03 |
COPD | 52 (19.8) | 28 (17.0) | 12 (16.0) | 0.66 |
Diabetes mellitus | 97 (36.9) | 65 (39.4) | 21 (28.0) | 0.23 |
Uremia | 18 (6.8) | 17 (10.3) | 9 (12.0) | 0.26 |
Thyroid disorder | 10 (3.8) | 10 (6.1) | 6 (8.0) | 0.29 |
Prior medication, n (%) | ||||
Beta blocker | 29 (11.0) | 27 (16.4) | 4 (5.3)b | 0.04 |
Calcium channel blocker | 9 (3.4) | 10 (6.1) | 2 (2.7) | 0.32 |